SLC6A8 and type 1 diabetes mellitus: When CARD9 was downregulated, SLC6A8‐mediated Cr uptake was impaired, driving macrophages toward a pro‐inflammatory phenotype and increasing the secretion of pro‐inflammatory cytokines that accelerated T1D progression.